Lab owners charged in $36M COVID-19 testing fraud scheme

Three owners of an independent laboratory have been charged for their alleged roles in a $36 million fraud scheme. 

Advertisement

The three men allegedly submitted false claims for COVID-19 testing to healthcare benefit programs, including Medicare and the Health Resources and Services Administration’s COVID-19 Uninsured Program, according to an April 24 Justice Department news release. The alleged scheme occurred between November 2018 and June 2023. 

They also allegedly paid illegal kickbacks and bribes to patient recruiters who arranged for healthcare providers to refer the tests to their lab, Innovative Genomics. 

The men charged in the indictment are: 

  • Enrique Perez-Paris, 47, of Aventura, Fla. 
  • Diego Sanudo Sanchez Chocron, 47, of Venice, Calif.
  • Gregory Caskey, 57, of San Antonio

The three are each charged with conspiracy to commit healthcare fraud and wire fraud, three counts of healthcare fraud and conspiracy to commit money laundering.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.